Research and Markets (http://www.researchandmarkets.com/research/2hsp5v/global_minimally) has announced the addition of the "Global Minimally Invasive VCF Devices Market & Forecasts Report, 2016" report to their offering.

One of the major growth factors driving the Global Minimally Invasive VCF Devices market is the increasing incidence of osteoporosis. About 85 percent of the VCF cases are due to osteoporosis.

Companies are also focusing on reducing the risks associated with the VCF treatments during and after surgery. Thus, they are coming up with advanced equipment which reduces the risk of cement leakage during surgery. Further, as a result of the latest innovations in VCF products, the risk in the vertebroplasty procedure is getting reduced. Furthermore, the quality of the balloons introduced during the kyphoplasty procedure is also being improved so as to reduce the leakage of the cement inserted inside them during the surgery.

Further, the report states that , most VCF treatments are expensive for patients in developing nations. Kyphoplasty treatments are much more expensive than vertebroplasty treatments, which could affect the future growth of the Global Minimally Invasive VCF Devices market. Moreover, the high price of these treatments is also due to the monopolistic approach in this market, where Medtronic has acquired almost 80-82 percent of the market share. Hence, this market lacks competitive pricing.

The key vendors dominating this market space are:

  • Medtronic Inc.
  • Stryker Corp.
  • Carefusion Corp.
  • De Puy Spine Inc.
  • Zimmer Holdings Inc.

Key Topics Covered:

01. Executive Summary

02. Scope of the Report

03. Market Research Methodology

04. List of Abbreviations

05. Introduction

06. Market Landscape

07. Market Segmentation by Technology

07.1 Global Minimally Invasive VCF Devices Market by Technology 2012-2016

07.2 Global Vertebroplasty Market

07.3 Global Kyphoplasty Market

07.4 Global Minimally Invasive VCF Devices Market Segmentation by Technology 2012-2016

08. Complications Associated with Vertebroplasty and Kyphoplasty

09. Geographical Segmentation

10. Key Leading Countries

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/2hsp5v/global_minimally

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices